3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
155
Leukemia, Lymphocytic, Chronic, B-Cell
43
Lymphoma, Large B-Cell, Diffuse
26
Lymphoma
25
Lymphoma, Non-Hodgkin
23
Lymphoma, Mantle-Cell
23
Lymphoma, Follicular
23
Leukemia
22
Recurrence
21
Neoplasms, Plasma Cell
19
Myelodysplastic Syndromes
12
Lymphoma, B-Cell, Marginal Zone
12
Leukemia, Myeloid, Acute
12
Waldenstrom Macroglobulinemia
8
Smoldering Multiple Myeloma
8
Hodgkin Disease
8
Prostatic Neoplasms
7
Lymphoma, B-Cell
6
Lymphoma, T-Cell
5
Lymphoma, Large-Cell, Anaplastic
5
Hematologic Diseases
5
Sezary Syndrome
4
Mycosis Fungoides
4
Lymphoma, T-Cell, Peripheral
4
Leukemia, Myelomonocytic, Chronic
4
Immunoblastic Lymphadenopathy
4
Anemia
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Polycythemia Vera
3
Lymphoma, T-Cell, Cutaneous
3
Interventions
Temozolomide
53
Bevacizumab
33
Radiotherapy
27
Radiation
12
Erlotinib Hydrochloride
12
Radiotherapy, Intensity-Modulated
8
Radiotherapy, Conformal
8
Irinotecan
6
Vorinostat
5
Sorafenib
5
Sirolimus
5
temsirolimus
4
Magnetic Resonance Spectroscopy
4
Immunoglobulin G
4
Disulfides
4
Carmustine
4
veliparib
3
plerixafor
3
carmustine, poliferprosan 20 drug combination
3
Radiosurgery
3
Everolimus
3
Dasatinib
3
Bortezomib
3
vandetanib
2
tandutinib
2
sargramostim
2
poly ICLC
2
pembrolizumab
2
pazopanib
2
ferric pyrophosphate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gliosarcoma
×
Lenalidomide
×
Clear all
No trials found.